Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...
Vous n'êtes pas connecté
The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects one in four people.
Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
THURSDAY, Aug. 29, 2024 -- People with chronic liver disease (CLD) have a higher likelihood of barriers to health care, according to a study recently...
A new study suggests that depression in some people might be linked to the same toxic plaques in the brain that are associated with Alzheimer’s...
Mammals, from the mighty blue whale to the tiny shrew, inhabit nearly every corner of our planet. Their remarkable adaptability to different...
FRIDAY, Aug. 30, 2024 -- Multiple sclerosis (MS) is associated with a lower risk for Alzheimer disease, according to a study published in the...